Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
Go back to Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 1.19 +0.06 (5.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.13 | 52 Week High | $0.04 | |||
| Open | $1.14 | 52 Week Low | $0.00 | |||
| Day High | $1.19 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $0.00 | |||
| Volume | 102,895 | |||||
